Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ICE/OCS stock hub

ICE/OCS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ICE/OCSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

235.9B

Nasdaq Iceland

Market data

Live price

Current market quote for this ticker.

Current price

ICE/OCS

In the news

Latest news · ICE/OCS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 90.7P50 90.7P75 90.7

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-73.5

P25 -73.5P50 -73.5P75 -73.5

ROIC-37.4

P25 -31.6P50 -25.9P75 -20.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ICE/OCS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

CHF

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	IS
Employees	60
Employees Change	11%
Employees Change Percent	22.45
Enterprise value	ISK 203.4B
Exchange	Nasdaq Iceland
Financial currency	CHF
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	ISK 235.9B
Price	ISK 3,950
Price currency	ISK
Rev Per Employee	3,159,481.05x
Sector	Healthcare
Sic	2836
Symbol	ice/OCS
Website	https://oculis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.63%
EV Earnings	-13x
EV/FCF	-19.32x
FCF yield	-4.46%
P/B ratio	7.61x
P/S ratio	1,244.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	ISK -8.8B
Net Income	ISK -15.6B
Pretax Margin	-8,268.81%
Profit Per Employee	ISK -260.8M
ROA	-28.65
Roa5y	-34.05
ROCE	-41
ROE	-73.45
ROIC	-37.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	70.32%
Revenue Growth	74.78x
Revenue Growth Q	13,600x
Revenue Growth3 Y	9.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ISK 0.01
Assets	ISK 37.3B
Cash	ISK 33.7B
Current Assets	ISK 34.4B
Current Liabilities	ISK 5.8B
Debt	ISK 365.7M
Debt Equity	ISK 0.01
Debt FCF	ISK -0.03
Equity	ISK 31B
Interest Coverage	-98.05
Liabilities	ISK 6.3B
Long Term Assets	ISK 2.9B
Long Term Liabilities	ISK 536.7M
Net Cash	ISK 33.3B
Net Cash By Market Cap	ISK 14.12
Net Cash Growth	116.14%
Net Debt Equity	ISK -1.07
Tangible Book Value	ISK 28.9B
Tangible Book Value Per Share	ISK 498
WACC	5.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.96
Net Working Capital	ISK -4.8B
Quick ratio	5.85
Working Capital	ISK 28.8B
Working Capital Turnover	ISK 1.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	70.26%
200-day SMA	2,756.8
50-day SMA	3,382.3
50-day SMA vs 200-day SMA	50over200
All Time High	3,960
All Time High Change	-0.25%
All Time High Date	2026-05-08
All Time Low	1,500
All Time Low Change	163.33%
All Time Low Date	2024-07-10
ATR	121
Beta	0.2
Ch YTD	53.7
High	3,960
High52	3,960
High52 Date	2026-05-08
High52ch	-0.25%
Low	3,760
Low52	1,965
Low52 Date	2025-08-29
Low52ch	101.02%
Ma50ch	16.78%
Price vs 200-day SMA	43.28%
RSI	72.26
RSI Monthly	68.82
RSI Weekly	72.15
Sharpe ratio	1.64x
Sortino ratio	3.2
Total Return	-29.29%
Tr YTD	53.7
Tr1m	20.06%
Tr1w	14.49%
Tr3m	14.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ISK -12.9B
Operating margin	-6,811.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,879,978%
Net Borrowing	-58,574,473.4
Shares Insiders	3.95%
Shares Institutions	27.26%
Shares Qo Q	6.92%
Shares Yo Y	29.29%
Short Ratio	1.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ISK -13.1B
Average Volume	30,826.2x
Bv Per Share	534.6
CAPEX	ISK -47.6M
Ch1m	20.06
Ch1w	14.49
Ch1y	70.26
Ch3m	14.83
Ch6m	61.89
Change	3.4%
Change From Open	5.05
Close	3,820
Days Gap	-1.57
Depreciation Amortization	23,869,490.5
Dollar Volume	219,118,350
Earnings Date	2026-05-07
EBIT	ISK -12.9B
EBITDA	ISK -12.9B
EPS	ISK -299
F Score	4
FCF	ISK -10.5B
FCF EV Yield	-5.18x
Financing CF	29,552,821,313
Fiscal Year End	December
Founded	2,017
Income Tax	ISK -29.4M
Investing CF	-9,634,019,270
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Ma150	2,964.7
Ma150ch	33.24%
Ma20	3,429
Ma20ch	15.19%
Net CF	8,477,791,500
Next Earnings Date	2026-05-11
Open	3,760
Position In Range	95
Ppne	470,637,257
Price Date	2026-05-08
Ptbv Ratio	8.16
Relative Volume	1.8x
Revenue	189,568,863x
SBC By Revenue	1,338.12x
Share Based Comp	2,536,649,574
Tax By Revenue	-15.51x
Tr6m	61.89%
Volume	55,473
Z Score	10.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ICE/OCS pay a dividend?

Capital-return profile for this ticker.

Performance

ICE/OCS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ICE/OCS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.3%

Share of float held by funds and institutions

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ICE/OCS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.3

Above 70: short-term overbought

Price vs 200-day MA

+43.3%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

1.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ICE/OCS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ice/OCS stock rating?

ice/OCS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ice/OCS analysis?

The full report lives at /stocks/ice/OCS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ice/OCS?

The latest report frames ice/OCS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ice/OCS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.